Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Beth Israel Deaconess Medical Center
ClinicalTrials.gov Identifier:
NCT00127491
First received: August 4, 2005
Last updated: December 9, 2013
Last verified: December 2013

August 4, 2005
December 9, 2013
May 2004
August 2007   (final data collection date for primary outcome measure)
Oxygenation as measured by the PO2/FiO2 (P/F) ratio [ Time Frame: 72 hours from enrollment ] [ Designated as safety issue: Yes ]
Oxygenation as measured by the PO2/FiO2 (P/F) ratio
Complete list of historical versions of study NCT00127491 on ClinicalTrials.gov Archive Site
  • Ventilator free days [ Time Frame: At 28 days ] [ Designated as safety issue: No ]
  • Markers of inflammation [ Time Frame: In first 72 hours ] [ Designated as safety issue: No ]
  • Mortality [ Time Frame: At 28, 90 and 180 days ] [ Designated as safety issue: No ]
  • Length of stay [ Time Frame: Hospital and ICU ] [ Designated as safety issue: No ]
  • Ventilator free days
  • Length of stay
  • Markers of inflammation
  • Mortality
Not Provided
Not Provided
 
Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury
A RCT of Mechanical Ventilation, Directed by Esophageal Pressure Measurements, in Patients With Acute Lung Injury

The purpose of this study is to see whether esophageal pressure (PES) measurements will allow the investigators to choose the best method of mechanical ventilation in patients with acute lung injury (ALI).

The current standard of practice for ventilating patients with acute respiratory distress syndrome (ARDS) is the ARDSnet protocol (N Engl J Med 2000; 342:1301-1308) which has been shown to improve survival by limiting tidal volumes and thus preventing over distention of the lungs. However, the lungs can also be damaged by under-inflation during mechanical ventilation, and current practice ignores the effects of chest wall compression of the lungs, which can cause under-inflation. The investigators have observed that a fraction of critically ill patients with apparent ARDS have lung function abnormalities caused by extrinsic compression which can be estimated by PES measurements. Changing ventilator settings to apply normal physiological pressure to the lung has been beneficial in many such patients. This protocol will formally test the clinical utility of PES measurements in patients with ARDS.

This is a randomized controlled trial of therapy directed by esophageal balloon measurements (PES) versus therapy directed by ARDSnet protocol, the current standard of care.

Interventional
Phase 2
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Acute Lung Injury
  • Acute Respiratory Distress Syndrome
Procedure: Placement of an esophageal balloon measurements
In both groups an esophageal balloon will be placed and baseline measurements recorded. In the EP group the mechanical ventilation settings will be determined based on these measurements. In the control group measurements will be recorded but ventilation will be based in the existing standard of care wich is the ARDSnet low tidal volume ventilation study. measurements will be repeated at 24, 48 and 72 hours or as needed.
  • Experimental: EP
    Ventilation directed by esophageal balloon measurements to maintain a positive trans-pulmonary pressure at end expiration
    Intervention: Procedure: Placement of an esophageal balloon measurements
  • Active Comparator: Control
    Ventilation based on the ARDSnet low tidal volume study
    Intervention: Procedure: Placement of an esophageal balloon measurements

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
63
May 2010
August 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

Patients with ALI/ARDS according to the International Consensus Conference criteria:

  • PaO2/FiO2 ratio < 300
  • Acute onset
  • Bilateral infiltrates on chest radiography
  • PAOP < 18 or, in patients without a pulmonary artery catheter, no other evidence of abnormal cardiac function

Exclusion Criteria:

  • Patients with esophageal varices
  • Patients with esophageal trauma
  • Patients with recent esophageal surgery
  • Patients with coagulopathy (platelets < 80k or International Normalized Ratio [INR]> 2 )
  • Post transplant patients
  • Patients with significant broncho-pleural fistula
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00127491
2004-P-000011/1; BIDMC, RO1 HL 52586
Yes
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Daniel S Talmor, MD, MPH Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center
December 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP